PT  - JOURNAL ARTICLE
AU  - Coleman, Thomas S.
TI  - Estimating Lower Bounds for COVID-19 Mortality from Northern Italian Towns
AID  - 10.1101/2020.06.10.20125005
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.10.20125005
4099  - http://medrxiv.org/content/early/2020/06/12/2020.06.10.20125005.short
4100  - http://medrxiv.org/content/early/2020/06/12/2020.06.10.20125005.full
AB  - For COVID-19 the Infection Fatality Rate or IFR – a crucial variable in epidemiological modeling – is difficult to estimate because many cases are asymptomatic and the overall infection rate is generally not known. Circumstances in the Italian provinces of Milano, Bergamo, Brescia, and Lodi allow estimation of lower bounds for age- and sex-specific all-cause excess mortality (a proxy for IFR) since anecdotal reports indicate some towns were close to fully infected. Using data from ISTAT on mortality from January 1 through April 15 for 2020 and the three preceding years, I estimate excess mortality by sex and age categories (0-14, 15-54, 55-64, 65-74, and 75+ years) while controlling for town-specific mortality that proxies for town-specific infection rate. The 99th percentile from the tail of the town distribution gives a lower-bound estimate for COVID-19 mortality. The overall population-weighted mortality at the 99th percentile is 1.09 percent (95% CI 1.06-1.14). The age- and sex-specific rates vary considerably: for men age 65-74 the estimate is 2.10 percent (95% CI 1.94-2.28) which is 3.5-times higher than men 55-64 and 2.7-times higher than women 65-74.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was provided for this researchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was applied for or granted. The data used are published by ISTAT (Istituto nazionale di statistica, the Italian national statistical institute) and are publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll mortality and population data are publicly available from ISTAT https://www.istat.it/it/archivio/240401 http://demo.istat.it/pop2019/index3.html